New Quinazolin-4(3H)-one Derivatives as Potential Antitumoral Compounds: Synthesis, In Vitro Cytotoxicity Against the HepG2 Cell Line, and In Silico VEGFR-2 Targeting-Based Studies
Molecules · 09.12.2025 · 30 (24) · 4719
DOI: 10.3390/molecules30244719 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 09.12.2025. Verfasst von Raluca Pele und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cl…. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Antineoplastic Agents, Quinazolinones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Three new 2,3-disubstituted quinazolin-4(3H)-one derivatives (5a–c) were synthesized by the nucleophilic S-alkylation of 2-mercaptoquinazolin-4(3H)-one derivatives (3a–c) with 5-(2-bromoacetyl)-2-hydroxybenzamide (4) in alkaline conditions. The final compounds were characterized by recording the IR, MS, 1H-NMR, and 13C-NMR spectra. The new synthesized compounds 5a–c were evaluated in vitro for their cytotoxic activity using one normal cell line, human foreskin fibroblasts (BJ), and one cancerous cell line, derived from human hepatocellular carcinoma (HepG2). Sorafenib was used as a reference. The obtained results from the in vitro examination suggested that compound 5a had lower cytotoxic effects on the BJ cells than the positive standard, and compound 5b exhibited the strongest cytotoxic potential against the HepG2 cell line, being less effective compared to sorafenib. In order to evaluate their pharmacological profiles, the compounds were assessed in vitro and in silico by lipophilicity studies, targeted VEGFR-2 molecular docking, molecular dynamics, and MM-PBSA studies. Additionally, the electronic properties were evaluated by an in silico study of the HOMO and LUMO parameters. Compound 5b exhibited the most interesting pharmacological profile in comparison with the other compounds due to its bulkier substituent from position 3 of the quinazolinone core.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
- Department of Organic Chemistry, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
- Department of Radiobiology and Tumor Biology, "Prof. Dr. Ion Chiricuță" Oncology Institute, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania.
- Research Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University of Galați, 47 Domneasca Street, 800008 Galați, Romania.
- National Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donath Street, 400293 Cluj-Napoca, Romania.
- Department of Pharmaceutical Technology and Biopharmaceutics, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
ORCID-Profile: Raluca Pele, Gabriel Marc, Brîndușa Tiperciuc, Anca Stana, Adrian Pîrnău, Laurian Vlase, Daniel Ungureanu
Zitieren
APA
Pele, R., Marc, G., Tiperciuc, B., Ionuț, I., Stana, A., Moldovan, C., Tatomir, C., Dragostin, O. M., Pîrnău, A., Vlase, L., Ungureanu, D., & Oniga, O. (2025). New Quinazolin-4(3H)-one Derivatives as Potential Antitumoral Compounds: Synthesis, In Vitro Cytotoxicity Against the HepG2 Cell Line, and In Silico VEGFR-2 Targeting-Based Studies. Molecules, 30(24), 4719. https://doi.org/10.3390/molecules30244719
Vancouver
Pele R, Marc G, Tiperciuc B, Ionuț I, Stana A, Moldovan C, et al. New Quinazolin-4(3H)-one Derivatives as Potential Antitumoral Compounds: Synthesis, In Vitro Cytotoxicity Against the HepG2 Cell Line, and In Silico VEGFR-2 Targeting-Based Studies. Molecules. 2025;30(24):4719. doi:10.3390/molecules30244719
BibTeX
@article{Pele2025,
author = {Pele, Raluca and Marc, Gabriel and Tiperciuc, Brîndușa and Ionuț, Ioana and Stana, Anca and Moldovan, Cristina and Tatomir, Corina and Dragostin, Oana Maria and Pîrnău, Adrian and Vlase, Laurian and Ungureanu, Daniel and Oniga, Ovidiu},
title = {New Quinazolin-4(3H)-one Derivatives as Potential Antitumoral Compounds: Synthesis, In Vitro Cytotoxicity Against the HepG2 Cell Line, and In Silico VEGFR-2 Targeting-Based Studies},
journal = {Molecules},
year = {2025},
volume = {30},
number = {24},
pages = {4719},
doi = {10.3390/molecules30244719}
}
EUVIMED